Company intelligence
Edgewise Therapeutics
On a mission to improve the lives of people facing serious cardiovascular diseases.
Biotechnology Research
Boulder, US
142 employees
Founded 2017
1 public signals
About Edgewise Therapeutics
Edgewise Therapeutics, Inc. (Nasdaq: EWTX) is a leading clinical-stage biopharmaceutical company focused on cardiovascular diseases.
Verified activity
Signals from Edgewise Therapeutics
1 published signal